Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors
Lise T. Jensen, Kathrine E. Attfield, Marc Feldmann, et al.
EBioMedicine (2023) Vol. 97, pp. 104840-104840
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Topical TYK2 inhibitor ameliorates psoriasis‐like dermatitis via the AKT‐SP1‐NGFR‐AP1 pathway in keratinocytes
Zhiqin Fang, Rundong Jiang, Yutong Wang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 10
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats
Adediwura Arowosegbe, Zhiru Guo, Emma Vanderleeden, et al.
Journal of Autoimmunity (2025) Vol. 151, pp. 103358-103358
Closed Access
Novel therapies in SLE treatment: A literature review
Jakub Mastalerz, Alicja Dąbrowska, Wojciech Plizga, et al.
Advances in Clinical and Experimental Medicine (2025) Vol. 34, Iss. 11
Open Access
Macrophages Unmasked: Their Pivotal Role in Driving Atherosclerosis in Systemic Lupus Erythematosus
Chao Wang, B Chen, Xiaochen Yu, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions
Anzhelika Karjalainen, Agnieszka Witalisz‐Siepracka, Michaela Prchal‐Murphy, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Linderae Radix extract attenuates ulcerative colitis by inhibiting the JAK/STAT signaling pathway
Yingying Wang, Weizhi Lai, Xunjie Zheng, et al.
Phytomedicine (2024) Vol. 132, pp. 155868-155868
Closed Access | Times Cited: 4
TYK2:p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels
Maristella Steri, Valeria Orrù, Carlo Sidore, et al.
Immunology (2025)
Open Access
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
Peter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Exploring the Efficacy, Safety, and Clinical Implications of Deucravacitinib in East Asians with Psoriasis: A Narrative Review
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1746-1746
Open Access
Rôle des lymphocytes T résidents mémoires dans les maladies inflammatoires du système nerveux central
Roland Liblau
Bulletin de l Académie Nationale de Médecine (2025)
Closed Access
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulator
Tyler P. Molitor, Genki Hayashi, Mei-Yao Lin, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 13
Open Access
Exploring the effect of deucravacitinib in patients with palmoplantar pustular psoriasis
David A. De Luca, Cristian Papara, Tomasz Hawro, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 3
Theoretical Studies of DNA Microarray Present Potential Molecular and Cellular Interconnectivity of Signaling Pathways in Immune System Dysregulation
Jon Patrick T. Garcia, Lemmuel L. Tayo
Genes (2024) Vol. 15, Iss. 4, pp. 393-393
Open Access | Times Cited: 2
Ultrarare Variants in DNA Damage Repair Genes in Pediatric Acute-Onset Neuropsychiatric Syndrome or Acute Behavioral Regression in Neurodevelopmental Disorders
Janet L. Cunningham, Jennifer Frankovich, Robert Dubin, et al.
Developmental Neuroscience (2024), pp. 1-20
Open Access | Times Cited: 2
Dual‐Action Psoriasis Therapy: Antiproliferative and Immunomodulatory Effects via Self‐Locking Microneedles
Ziyi Wang, Ze Qiang Zhao, Yu Sheng, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
Ultrarare Variants in DNA Damage Repair Genes in Pediatric Acute-Onset Neuropsychiatric Syndrome or Acute Behavioral Regression in Neurodevelopmental Disorders
Janet L. Cunningham, Jennifer Frankovich, Robert Dubin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Janus Kinases and Autoimmunity: Bridging Pathways to Therapy
Yazi Wei, Tiantai Zhang
International Journal of Drug Discovery and Pharmacology (2024), pp. 100007-100007
Closed Access | Times Cited: 1
Prodrug Strategy to Address Impaired Oral Absorption of a Weakly Basic TYK2 Inhibitor Caused by a Gastric Acid-Reducing Agent
Murugaiah A. M. Subbaiah, Thangeswaran Ramar, Maheswara Reddy, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Lack of TYK2 signaling enhances host resistance to Candida albicans skin infection
Sara Miranda, Caroline Lassnig, Kristina Schmidhofer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Kinase-Bench: Comprehensive Benchmarking Tools and Guidance for Achieving Selectivity in Kinase Drug Discovery
Tian‐Hua Wei, Shuangshuang Zhou, Xiaolong Jing, et al.
Journal of Chemical Information and Modeling (2024)
Closed Access | Times Cited: 1
Deucravacitinib shows superior efficacy and safety in cutaneous lupus erythematosus compared to various biologics and small molecules – A systematic review and META-analysis
Laura Bokor, Katalin Martyin, Máté Krebs, et al.
Autoimmunity Reviews (2024), pp. 103723-103723
Open Access | Times Cited: 1
Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 2, pp. 174-176
Closed Access
Sjogren’s Syndrome: Strategies for Treatment
Arthur Bookman
Canadian rheumatology today. (2024)
Closed Access
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral allosteric TYK2 inhibitor ESK‐001 using a randomized, double‐blind, placebo‐controlled study design
Sibel Ucpinar, John Kwan, Joshua Hoffman, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Closed Access
Page 1 - Next Page

Scroll to top